Ernexa Therapeutics Inc. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-K405
10-Q
10-Q/A
15-12G
25
3
3/A
4
4/A
424B3
424B5
425
5
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DEFS14A
DRS
EFFECT
NT 10-K
NT 10-K/A
NT 10-Q
POS AM
PRE 14A
PRES14A
REGDEX
RW
S-1
S-1/A
S-3
S-3/A
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-032060 | Apr 4, 2025 | Apr 2, 2025 |
| 8-K | — | 0001641172-25-002514 | Apr 3, 2025 | Mar 31, 2025 |
| PRE 14A | — | 0001641172-25-002606 | Apr 3, 2025 | Dec 31, 2024 |
| 8-K | — | 0001641172-25-000681 | Mar 26, 2025 | — |
| 8-K | — | 0001641172-25-000300 | Mar 24, 2025 | Mar 20, 2025 |
| 10-K | — | 0001493152-25-010051 | Mar 12, 2025 | Dec 31, 2024 |
| 8-K | — | 0001493152-25-010049 | Mar 12, 2025 | Mar 11, 2025 |
| SCHEDULE 13D/A | — | 0001104659-25-020984 | Mar 5, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-021705 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001213900-25-014538 | Feb 14, 2025 | — |
| 8-K | — | 0001493152-25-006446 | Feb 13, 2025 | Feb 7, 2025 |
| SCHEDULE 13G/A | — | 0001104659-25-012308 | Feb 12, 2025 | — |
| 4 | — | 0001493152-25-005721 | Feb 10, 2025 | Feb 7, 2025 |
| 4 | — | 0001493152-25-005719 | Feb 10, 2025 | Feb 7, 2025 |
| 4 | — | 0001493152-25-005722 | Feb 10, 2025 | Feb 7, 2025 |
| 4 | — | 0001493152-25-005718 | Feb 10, 2025 | Feb 7, 2025 |
| 4 | — | 0001493152-25-005720 | Feb 10, 2025 | Feb 7, 2025 |
| SCHEDULE 13G/A | — | 0000950170-25-009968 | Jan 28, 2025 | — |
| 4 | — | 0001493152-25-002206 | Jan 14, 2025 | Jan 13, 2025 |
| 3 | — | 0001493152-25-002184 | Jan 14, 2025 | Jan 7, 2025 |
| 8-K | — | 0001493152-25-001704 | Jan 10, 2025 | Jan 3, 2025 |
| 8-K | — | 0001493152-25-000246 | Jan 3, 2025 | Dec 30, 2024 |
| 424B3 | — | 0001493152-24-046509 | Nov 18, 2024 | — |
| 424B3 | — | 0001493152-24-046510 | Nov 18, 2024 | — |
| 424B3 | — | 0001493152-24-046511 | Nov 18, 2024 | — |
| EFFECT | — | 9999999995-24-003503 | Nov 15, 2024 | — |
| D | — | 0001493152-24-045322 | Nov 14, 2024 | — |
| D | — | 0001493152-24-045321 | Nov 14, 2024 | — |
| CORRESP | — | 0001493152-24-045187 | Nov 13, 2024 | — |
| UPLOAD | — | 0000000000-24-012578 | Nov 13, 2024 | — |
| 10-Q | — | 0001493152-24-044841 | Nov 12, 2024 | Sep 30, 2024 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-24-114222 | Nov 5, 2024 | Sep 23, 2024 |
| S-1 | — | 0001493152-24-043663 | Nov 5, 2024 | — |
| 8-K | — | 0001493152-24-042902 | Oct 29, 2024 | — |
| ARS | — | 0001493152-24-041302 | Oct 16, 2024 | Dec 31, 2023 |
| DEF 14A | — | 0001493152-24-040286 | Oct 7, 2024 | — |
| PRE 14A | — | 0001493152-24-038561 | Sep 27, 2024 | — |
| 8-K | — | 0001493152-24-038532 | Sep 27, 2024 | Sep 24, 2024 |
| 8-K | — | 0001493152-24-038129 | Sep 25, 2024 | Sep 24, 2024 |
| 8-K | — | 0001493152-24-037815 | Sep 23, 2024 | Sep 17, 2024 |
| 8-K | — | 0001493152-24-033119 | Aug 19, 2024 | Aug 16, 2024 |
| 10-Q | — | 0001493152-24-031639 | Aug 13, 2024 | Jun 30, 2024 |
| 4 | — | 0001493152-24-025105 | Jun 25, 2024 | Jun 21, 2024 |
| 10-Q | 10-Q | 0001140361-24-026010 | May 14, 2024 | Mar 31, 2024 |
| 4 | FORM 4 | 0001140361-24-023012 | Apr 29, 2024 | Apr 26, 2024 |
| 4 | FORM 4 | 0001140361-24-023011 | Apr 29, 2024 | Apr 26, 2024 |
| 4 | FORM 4 | 0001140361-24-023013 | Apr 29, 2024 | Apr 26, 2024 |
| 8-K | 8-K | 0001140361-24-014809 | Mar 22, 2024 | Mar 19, 2024 |
| 10-K/A | 10-K/A | 0001140361-24-013709 | Mar 18, 2024 | Dec 31, 2023 |
| 10-K | 10-K | 0001140361-24-013254 | Mar 14, 2024 | Dec 31, 2023 |